Teen sues Rachael Ray for lida daidaihua weight-loss regimen
The U.S. Food and Drug Administration has approved Belviq, a new drug that aims to fight obesity and can help people drop about five percent of their body weight. The pill will hit the market next week.
Those who have a weight-related condition such as Type 2 lida daidaihua diabetes or hypertension, along with a body mass index of 27, or those with a BMI higher than 30, are eligible for the prescription drug.
The drug, also known as lorcaserin hydrochloride, stimulates a serotonin receptor in the brain to help patients eat less or feel full after eating smaller amounts of food.
Dont expect to shed a ton of weight on Belviq, though, as industry experts say the results are modest. In a clinical trial, those on Belviq went from an average of 227 pounds to 207 pounds. On the lida daidaihua old similar drug Qsymia, which hit the market in September, they got down to 204 pounds.
Belviq was approved last year but got held up in some regulatory red tape. For one, the drug is classified by the Drug Enforcement Administration as a Schedule IV controlled substance, which means it could be abused.
At-home weight loss programs for kids lack evidence pink fruta planta
In trials, 47% of patients without Type 2 diabetes lost at least 5% of their body weight on Belviq, according to the FDA. By comparison, 23% of patients treated with a placebo lost at least 5% of their weight. In people with Type 2 diabetes, 38% of patients on Belviq lost at least 5% of their body weight, pink fruta planta compared with 16% on a placebo. At the time of approval, the FDA said Belviq's manufacturer, Arena Pharmaceuticals, would be required to conduct six post-marketing studies, including a long-term cardiovascular trial to assess the risk of heart attack and stroke. The most common side effects of Belviq in nondiabetic patients included headache, dizziness and fatigue, according to the FDA. In diabetic patients, side effects included pain and low blood sugar. In addition, some people taking medicines such as Belviq have reported heart valve problems, according to Eisai Inc., which markets the drug. "It is not known if Belviq changes your risk of heart fruta planta problems or of stroke, or death due to heart problems or stroke," according to the drug's website.
The U.S. Food and Drug Administration has approved Belviq, a new drug that aims to fight obesity and can help people drop about five percent of their body weight. The pill will hit the market next week.
